|
|
|
|
|
|
by AlexandrB
1315 days ago
|
|
|
You're assuming that brand value has no financial value. Forget the stock price, this probably impacted EliLilly's brand in a way that will cost a bunch of money to "fix". If it sparks renewed calls for regulatory action on insulin prices, it could cost them quite a bit more than just brand value as well - either in lobbying, political "contributions", or profits. But that's speculation for now. |
|
|